These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Raviv Y; D'Ovidio F; Pierre A; Chaparro C; Freeman M; Keshavjee S; Singer LG Clin Transplant; 2012; 26(1):133-42. PubMed ID: 22313020 [TBL] [Abstract][Full Text] [Related]
92. Bronchiolitis obliterans syndrome development in lung transplantation patients. Parada MT; Alba A; Sepúlveda C Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344 [TBL] [Abstract][Full Text] [Related]
93. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040 [TBL] [Abstract][Full Text] [Related]
94. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome. Shitrit D; Amital A; Fox B; Kramer MR Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973 [TBL] [Abstract][Full Text] [Related]
95. Bronchiolitis obliterans in lung transplant recipients. The "thorn in the side" of lung transplantation. Levine SM; Bryan CL Chest; 1995 Apr; 107(4):894-7. PubMed ID: 7705149 [No Abstract] [Full Text] [Related]
96. A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans. Speich R; Boehler A; Russi EW; Weder W Respiration; 1997; 64(5):375-80. PubMed ID: 9311056 [TBL] [Abstract][Full Text] [Related]
97. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Cheng GS; Selwa KE; Hatt C; Ram S; Fortuna AB; Guerriero M; Himelhoch B; McAree D; Hoffman TC; Brisson J; Nazareno R; Bloye K; Johnson TD; Remberger M; Mattsson J; Vummidi D; Kazerooni EE; Lama VN; Galban S; Boeckh M; Yanik GA; Galban CJ Am J Transplant; 2020 Aug; 20(8):2198-2205. PubMed ID: 32034974 [TBL] [Abstract][Full Text] [Related]
98. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome. Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919 [TBL] [Abstract][Full Text] [Related]
99. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Verleden GM; Dupont LJ; Van Raemdonck DE Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284 [TBL] [Abstract][Full Text] [Related]
100. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE; Cowen EW; Justus DG; Baird K; Cheng GS; Avila D; Steinberg SM; Mitchell SA; Gress RE Transplant Cell Ther; 2022 May; 28(5):264.e1-264.e9. PubMed ID: 35114411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]